BANK VONTOBEL/CALL/MODERNA/145/0.1/20.09.24 Stock

Warrant

PQ45V

DE000VM7WHF1

Market Closed - Euronext Paris 12:30:01 2024-05-24 pm EDT
3.31 EUR +10.33% Intraday chart for BANK VONTOBEL/CALL/MODERNA/145/0.1/20.09.24
Current month+416.39%
1 month+517.65%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-24 3.15 +5.00%
24-05-23 3 +16.28%
24-05-22 2.58 +77.93%
24-05-21 1.45 +2.11%
24-05-20 1.42 +24.56%

Real-time Euronext Paris

Last update May 24, 2024 at 12:30 pm EDT

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying MODERNA, INC.
IssuerLogo Issuer Vontobel Vontobel
PQ45V
ISINDE000VM7WHF1
Date issued 2024-01-04
Strike 145 $
Maturity 2024-09-20 (119 Days)
Parity 10 : 1
Emission price 1.17
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 3.38
Lowest since issue 0.278
Delta0.74x
Omega 3.476
Premium7.71x
Gearing4.67x
Moneyness 1.159
Difference Strike -21.61 $
Difference Strike %-14.90%
Spread 0.02
Spread %0.60%
Theoretical value 3.320
Implied Volatility 59.08 %
Total Loss Probability 37.39 %
Intrinsic value 2.125
Present value 1.195
Break even 181.01 €
Theta-0.06x
Vega0.03x
Rho0.03x

Company Profile

Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows: - revenue from product sales (95.7%) ; - revenues from grants (4%); - revenues from collaboration agreements (0.3%). At the end of 2021, the group possessed a portfolio of 15 products in clinical development, of which 3 in phase III, 8 in phase II and 4 in phase I, and 12 products in preclinical development. Net sales are distributed geographically as follows: the United States (33.4%), Europe (37.1%) and other (29.5%).
Sector
-
More about the company

Ratings for Moderna, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Moderna, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
166.6 USD
Average target price
138.5 USD
Spread / Average Target
-16.86%
Consensus
  1. Stock Market
  2. Warrants
  3. PQ45V Warrant